Cholinergic Anti-Inflammatory Pathway and the Liver

Area of Science:

• Neurogastroenterology
• Immunology
• Hepatology

Background:

• The vagus nerve plays a key role in the liver-brain axis, modulating inflammation.
• Activation of vagal efferent fibers releases acetylcholine, inhibiting inflammatory cytokines via α7 nicotinic acetylcholine receptors (α7nAChRs) on liver cells.
• This cholinergic anti-inflammatory pathway is protective in liver diseases.

Purpose of the Study:

• To review the impact and significance of the cholinergic anti-inflammatory pathway in the liver.
• To discuss the dysfunction of this pathway in chronic liver disease and cirrhosis progression.
• To explore potential therapeutic strategies for liver diseases, including sepsis in cirrhotic patients.

Main Methods:

• Literature review focusing on the vagus nerve, inflammation, and liver disease.
• Analysis of experimental studies on the protective role of the vagus-α7nAChR axis.
• Discussion of autonomic dysfunction in chronic liver disease and cirrhosis.

Main Results:

• The vagus nerve's cholinergic pathway inhibits liver inflammation through α7nAChRs.
• Autonomic dysfunction, including reduced vagal function, is a complication of chronic liver disease and cirrhosis.
• Dysfunction of the cholinergic anti-inflammatory pathway contributes to cirrhosis progression.

Conclusions:

• The vagus-α7nAChR axis is crucial for liver health, but its function is impaired in cirrhosis.
• Therapeutic strategies targeting this pathway, such as drug targeting and electrical nerve stimulation, may benefit cirrhotic patients, especially those at risk of sepsis.